Psoriasis drug safety check: brodalumab under the microscope
NCT ID NCT03254667
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 25 times
Summary
This study watches adults with moderate-to-severe psoriasis who are taking brodalumab or other psoriasis medications to see how safe they are over time. Researchers are especially looking for any new cancers. About 3,500 people will take part, and the study just observes their regular care without changing treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Registry
Bridgewater, New Jersey, 08807, United States
Conditions
Explore the condition pages connected to this study.